
LINK . SPRINGER . COM {
}
Title:
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma | Molecular and Cellular Biochemistry
Description:
Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Graphical abstract Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure if the website is profiting.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, google, scholar, hepatocellular, carcinoma, cas, cancer, cells, wang, patients, zhang, cell, immunotherapy, oncol, liu, exosomes, liver, tumor, therapy, phase, advanced, immune, yang, res, treatment, trial, chen, radioimmunotherapy, hcc, clin, hepatol, study, antibody, jiang, sorafenib, research, antigens, targeted, mol, lancet, huang, immunol, blockade, future, current, int, biol, checkpoint, clinical, combination,
Topics {✒️}
fak-pi3k-akt-girdin signaling pathway release exosomal mir-23a-3p nf-κb/il-6/stat3 axis anti-pd-l1 antibody mpdl3280a tgf-β/smad signaling pathway 131i-anti-endoglin monoclonal antibody mir-199a-modified exosomes p53-dependent signaling pathway massoud vosough anti-vegf/vegfr therapy month download article/chapter pfkfb3-pd-l1 axis immune cell-derived exosomes increased α-fetoprotein concentrations pd-l1 significantly associates hbv-related hepatocellular carcinoma exosomal pd-l1 contributes small-cell lung cancer nonconventional antigen-presenting cells intra-tumoral expression levels pd-1 antibody increase immune-checkpoint inhibitors immune checkpoint inhibitors tumor-related exosomes contribute cancer-related death worldwide targeted alpha therapy hepatocellular carcinoma-derived exosomes advanced/metastatic hepatocellular carcinoma anti-cancer target targeted cancer therapy exposure-induced side effects molecular research center essential exosome components tgf-β signaling anti-angiogenic therapy anti-endoglin antibody immune checkpoint blockade epithelial–mesenchymal-transition epithelial-mesenchymal transition robo1-targeted radioimmunotherapy commonly accessible antigens exosome mir-335 cytotoxic t-lymphocyte tumor-specific monoclonal antibodies el-khoueiry ab regulatory immune cells dendritic cells pulsed anti-pd-1 response small molecule-based approaches differentiation antigens cd105
Questions {❓}
- Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE et al (2020) Extracellular vesicles as drug delivery systems: why and how?
- Lee HW, Cho KJ, Park JY (2020) Current status and future direction of immunotherapy in hepatocellular carcinoma: what do the data suggest?
- Mehlen P, Delloye-Bourgeois C, Chédotal A (2011) Novel roles for Slits and netrins: axon guidance cues as anticancer targets?
- Sahlin M, Bauden MP, Andersson R, Ansari DJTB (2015) Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?
Schema {🗺️}
WebPage:
mainEntity:
headline:Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
description:Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
datePublished:2022-06-16T00:00:00Z
dateModified:2022-06-16T00:00:00Z
pageStart:23
pageEnd:37
sameAs:https://doi.org/10.1007/s11010-022-04483-4
keywords:
Radioimmunotherapy
Hepatocellular carcinoma
Immune checkpoint inhibitor
Target antigens
Exosome antigens
Biochemistry
general
Cardiology
Cancer Research
Medical Biochemistry
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Figa_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Fig1_HTML.png
isPartOf:
name:Molecular and Cellular Biochemistry
issn:
1573-4919
0300-8177
volumeNumber:478
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mahsa Pourhamzeh
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Samieh Asadian
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
type:Person
name:Hamed Mirzaei
affiliation:
name:Kashan University of Medical Sciences
address:
name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
type:PostalAddress
type:Organization
type:Person
name:Azita Minaei
affiliation:
name:Qazvin University of Medical Sciences
address:
name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
type:PostalAddress
type:Organization
type:Person
name:Elahe Shahriari
affiliation:
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Anastasia Shpichka
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
type:Person
name:Hamidreza Aboulkheyr Es
affiliation:
name:University of Technology Sydney
address:
name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
type:PostalAddress
type:Organization
type:Person
name:Peter Timashev
url:http://orcid.org/0000-0001-7773-2435
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Moustapha Hassan
affiliation:
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
type:Person
name:Massoud Vosough
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
description:Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
datePublished:2022-06-16T00:00:00Z
dateModified:2022-06-16T00:00:00Z
pageStart:23
pageEnd:37
sameAs:https://doi.org/10.1007/s11010-022-04483-4
keywords:
Radioimmunotherapy
Hepatocellular carcinoma
Immune checkpoint inhibitor
Target antigens
Exosome antigens
Biochemistry
general
Cardiology
Cancer Research
Medical Biochemistry
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Figa_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Fig1_HTML.png
isPartOf:
name:Molecular and Cellular Biochemistry
issn:
1573-4919
0300-8177
volumeNumber:478
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mahsa Pourhamzeh
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Samieh Asadian
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
type:Person
name:Hamed Mirzaei
affiliation:
name:Kashan University of Medical Sciences
address:
name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
type:PostalAddress
type:Organization
type:Person
name:Azita Minaei
affiliation:
name:Qazvin University of Medical Sciences
address:
name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
type:PostalAddress
type:Organization
type:Person
name:Elahe Shahriari
affiliation:
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Anastasia Shpichka
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
type:Person
name:Hamidreza Aboulkheyr Es
affiliation:
name:University of Technology Sydney
address:
name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
type:PostalAddress
type:Organization
type:Person
name:Peter Timashev
url:http://orcid.org/0000-0001-7773-2435
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Moustapha Hassan
affiliation:
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
type:Person
name:Massoud Vosough
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Molecular and Cellular Biochemistry
issn:
1573-4919
0300-8177
volumeNumber:478
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
name:Kashan University of Medical Sciences
address:
name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
type:PostalAddress
name:Qazvin University of Medical Sciences
address:
name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
type:PostalAddress
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
name:University of Technology Sydney
address:
name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
type:PostalAddress
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Mahsa Pourhamzeh
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
name:Samieh Asadian
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:Hamed Mirzaei
affiliation:
name:Kashan University of Medical Sciences
address:
name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
type:PostalAddress
type:Organization
name:Azita Minaei
affiliation:
name:Qazvin University of Medical Sciences
address:
name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
type:PostalAddress
type:Organization
name:Elahe Shahriari
affiliation:
name:UC San Diego
address:
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
type:PostalAddress
type:Organization
name:Anastasia Shpichka
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
name:Hamidreza Aboulkheyr Es
affiliation:
name:University of Technology Sydney
address:
name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
type:PostalAddress
type:Organization
name:Peter Timashev
url:http://orcid.org/0000-0001-7773-2435
affiliation:
name:Sechenov First Moscow State Medical University
address:
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Sechenov First Moscow State Medical University
address:
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
type:PostalAddress
type:Organization
name:Lomonosov Moscow State University
address:
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
type:PostalAddress
type:Organization
email:[email protected]
name:Moustapha Hassan
affiliation:
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
name:Massoud Vosough
affiliation:
name:ACECR
address:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
type:PostalAddress
type:Organization
name:Karolinska Institute
address:
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(296)
- What are the earnings of https://www.springernature.com/gp/authors?
- What's the income generated by https://link.springernature.com/home/ each month?
- Profit of https://order.springer.com/public/cart
- Explore the financials of https://submission.nature.com/new-submission/11010/3
- Income figures for https://orcid.org/0000-0001-7773-2435
- What's the income of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- How much does http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics%202018%3A%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&journal=CA%3A%20Cancer%20J%20Clin&volume=68&issue=6&pages=394-424&publication_year=2018&author=Bray%2CF&author=Ferlay%2CJ&author=Soerjomataram%2CI&author=Siegel%2CRL&author=Torre%2CLA&author=Jemal%2CA generate monthly?
- Learn about the earnings of https://doi.org/10.1111%2Fjcmm.16875
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Advanced%20therapeutic%20modalities%20in%20hepatocellular%20carcinoma%3A%20novel%20insights&journal=J%20Cell%20Mol%20Med&doi=10.1111%2Fjcmm.16875&volume=25&issue=18&pages=8602-8614&publication_year=2021&author=Shokoohian%2CB&author=Negahdari%2CB&author=Aboulkheyr%20Es%2CH&author=Abedi-Valugerdi%2CM&author=Baghaei%2CK&author=Agarwal%2CT?
- What's https://doi.org/10.1016%2F0360-3016%2889%2990322-2's gross income?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Radioimmunotherapy%20for%20hepatocellular%20carcinoma%20%28HCC%29%20using%20131I-anti%20HCC%20isoferritin%20IgG%3A%20preliminary%20results%20of%20experimental%20and%20clinical%20studies&journal=Int%20J%20Radiat%20Oncol%2A%20Biol%2A%20Phys&doi=10.1016%2F0360-3016%2889%2990322-2&volume=16&issue=2&pages=319-323&publication_year=1989&author=Kang-Da%2CL&author=Zhao-You%2CT&author=Yan-Ming%2CB&author=Ji-Zhen%2CL&author=Feng%2CQ&author=Ai-Na%2CY?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Cheung%20N-KV%2C%20Press%20OWJNRC&journal=Radioimmunother%20Hum%20Tumours&volume=15&issue=6&publication_year=2015&author=Larson%2CSM&author=Carrasquillo%2CJA
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Radioimmunotherapy%E2%80%94a%20potential%20novel%20tool%20for%20pancreatic%20cancer%20therapy%3F&journal=Tumor%20Biol&doi=10.1007%2Fs13277-015-3479-y&volume=36&issue=6&pages=4053-4062&publication_year=2015&author=Sahlin%2CM&author=Bauden%2CMP&author=Andersson%2CR&author=Ansari%2CDJTB?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Hepatic%20arterial%20Iodine-131%E2%80%93labeled%20metuximab%20injection%20combined%20with%20chemoembolization%20for%20unresectable%20hepatocellular%20carcinoma%3A%20interim%20safety%20and%20survival%20data%20from%20110%20patients&journal=Cancer%20Biother%20Radiopharm&volume=25&issue=6&pages=657-663&publication_year=2010&author=Wu%2CL&author=Yang%2CY-F&author=Ge%2CN-J&author=Shen%2CS-Q&author=Liang%2CJ&author=Wang%2CY?
- Revenue of https://doi.org/10.3389%2Ffonc.2021.632256
- How much does http://scholar.google.com/scholar_lookup?&title=Beyond%20conventional%3A%20the%20new%20horizon%20of%20targeted%20therapy%20for%20the%20treatment%20of%20advanced%20non%20small%20cell%20lung%20cancer&journal=Front%20Oncol&doi=10.3389%2Ffonc.2021.632256&volume=11&publication_year=2021&author=Tartarone%2CA&author=Lapadula%2CV&author=Micco%2CC&author=Rossi%2CG&author=Ottanelli%2CC&author=Marini%2CA earn?
- Get to know what's the income of https://doi.org/10.2217%2Ffon-2018-0868
- http://scholar.google.com/scholar_lookup?&title=Anti-PD-1%20versus%20anti-PD-L1%20therapy%20in%20patients%20with%20pretreated%20advanced%20non-small-cell%20lung%20cancer%3A%20a%20meta-analysis&journal=Future%20Oncol&doi=10.2217%2Ffon-2018-0868&volume=15&issue=20&pages=2423-2433&publication_year=2019&author=Tartarone%2CA&author=Roviello%2CG&author=Lerose%2CR&author=Roudi%2CR&author=Aieta%2CM&author=Zoppoli%2CP income
- Find out how much https://doi.org/10.4110%2Fin.2020.20.e11 earns monthly
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Current%20status%20and%20future%20direction%20of%20immunotherapy%20in%20hepatocellular%20carcinoma%3A%20what%20do%20the%20data%20suggest%3F&journal=Immune%20Netw&doi=10.4110%2Fin.2020.20.e11&volume=20&issue=1&publication_year=2020&author=Lee%2CHW&author=Cho%2CKJ&author=Park%2CJY
- How much profit is https://doi.org/10.5694%2Fmja16.00586 making per month?
- How much money does http://scholar.google.com/scholar_lookup?&title=Management%20of%20adverse%20events%20related%20to%20new%20cancer%20immunotherapy%20%28immune%20checkpoint%20inhibitors%29&journal=Med%20J%20Aust&doi=10.5694%2Fmja16.00586&volume=205&issue=9&pages=418-424&publication_year=2016&author=Bourke%2CJM&author=O%27Sullivan%2CM&author=Khattak%2CMA generate?
- How much does https://doi.org/10.1016%2Fj.canlet.2019.12.002 generate monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Immunotherapy%20for%20hepatocellular%20carcinoma&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2019.12.002&volume=470&pages=8-17&publication_year=2020&author=Zongyi%2CY&author=Xiaowu%2CL
- How much does https://doi.org/10.1016%2FS0140-6736%2802%2908649-X rake in every month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Arterial%20embolisation%20or%20chemoembolisation%20versus%20symptomatic%20treatment%20in%20patients%20with%20unresectable%20hepatocellular%20carcinoma%3A%20a%20randomised%20controlled%20trial&journal=The%20Lancet&doi=10.1016%2FS0140-6736%2802%2908649-X&volume=359&issue=9319&pages=1734-1739&publication_year=2002&author=Llovet%2CJM&author=Real%2CMI&author=Monta%C3%B1a%2CX&author=Planas%2CR&author=Coll%2CS&author=Aponte%2CJ produce monthly?
- What's the financial outcome of https://doi.org/10.1371%2Fjournal.pone.0190098?
- Profit of http://scholar.google.com/scholar_lookup?&title=Combined%20Yttrium-90%20microsphere%20selective%20internal%20radiation%20therapy%20and%20external%20beam%20radiotherapy%20in%20patients%20with%20hepatocellular%20carcinoma%3A%20from%20clinical%20aspects%20to%20dosimetry&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0190098&volume=13&issue=1&publication_year=2018&author=Wang%2CT-H&author=Huang%2CP-I&author=Hu%2CY-W&author=Lin%2CK-H&author=Liu%2CC-S&author=Lin%2CY-Y
- Learn how profitable https://doi.org/10.3390%2Fcells11020305 is on a monthly basis
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Rhenium%20Perrhenate%20%28%28188%29ReO%284%29%29%20induced%20apoptosis%20and%20reduced%20cancerous%20phenotype%20in%20liver%20cancer%20cells&journal=Cells&doi=10.3390%2Fcells11020305&volume=11&issue=2&publication_year=2022&author=Asadian%2CS&author=Piryaei%2CA&author=Gheibi%2CN&author=Aziz%20Kalantari%2CB&author=Reza%20Davarpanah%2CM&author=Azad%2CM?
- Find out how much http://scholar.google.com/scholar_lookup?&title=An%20overview%20of%20targeted%20alpha%20therapy&journal=Tumor%20Biol&doi=10.1007%2Fs13277-011-0286-y&volume=33&issue=3&pages=573-590&publication_year=2012&author=Kim%2CY-S&author=Brechbiel%2CMW earns monthly
- https://doi.org/10.1016%2Fj.phrs.2020.105070's financial summary
- What's the income of http://scholar.google.com/scholar_lookup?&title=%CE%B2-radiating%20radionuclides%20in%20cancer%20treatment%2C%20novel%20insight%20into%20promising%20approach&journal=Pharmacol%20Res&doi=10.1016%2Fj.phrs.2020.105070&volume=160&publication_year=2020&author=Asadian%2CS&author=Mirzaei%2CH&author=Kalantari%2CBA&author=Davarpanah%2CMR&author=Mohamadi%2CM&author=Shpichka%2CA?
- How much does https://doi.org/10.1155/2014/492061 pull in?
- Find out how much https://doi.org/10.1155%2F2014%2F492061 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Radioimmunotherapy%3A%20a%20specific%20treatment%20protocol%20for%20cancer%20by%20cytotoxic%20radioisotopes%20conjugated%20to%20antibodies&journal=Sci%20World%20J&doi=10.1155%2F2014%2F492061&publication_year=2014&author=Kawashima%2CH's revenue stream
- How much does https://doi.org/10.1038%2Fnrgastro.2015.200 bring in each month?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Immunology%20in%20the%20liver%E2%80%94from%20homeostasis%20to%20disease&journal=Nat%20Rev%20Gastroenterol%20Hepatol&doi=10.1038%2Fnrgastro.2015.200&volume=13&issue=2&publication_year=2016&author=Heymann%2CF&author=Tacke%2CF?
- How profitable is https://doi.org/10.1016%2Fj.jhep.2015.12.002?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Gut%E2%80%93liver%20immunity&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2015.12.002&volume=64&issue=5&pages=1187-1189&publication_year=2016&author=Trivedi%2CPJ&author=Adams%2CDH?
- How much profit does https://doi.org/10.1038%2Fcmi.2015.112 make?
- How much money does http://scholar.google.com/scholar_lookup?&title=Modulation%20of%20liver%20tolerance%20by%20conventional%20and%20nonconventional%20antigen-presenting%20cells%20and%20regulatory%20immune%20cells&journal=Cell%20Mol%20Immunol&doi=10.1038%2Fcmi.2015.112&volume=13&issue=3&pages=277-292&publication_year=2016&author=Horst%2CAK&author=Neumann%2CK&author=Diehl%2CL&author=Tiegs%2CG generate?
- How much does https://doi.org/10.1038%2Fni.2691 make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Immune%20surveillance%20by%20the%20liver&journal=Nat%20Immunol&doi=10.1038%2Fni.2691&volume=14&issue=10&pages=996-1006&publication_year=2013&author=Jenne%2CCN&author=Kubes%2CP produce monthly?
- Monthly income for https://doi.org/10.1016%2Fj.jhep.2019.04.007
- How much money does http://scholar.google.com/scholar_lookup?&title=Glycolytic%20activation%20of%20peritumoral%20monocytes%20fosters%20immune%20privilege%20via%20the%20PFKFB3-PD-L1%20axis%20in%20human%20hepatocellular%20carcinoma&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2019.04.007&volume=71&issue=2&pages=333-343&publication_year=2019&author=Chen%2CD-P&author=Ning%2CW-R&author=Jiang%2CZ-Z&author=Peng%2CZ-P&author=Zhu%2CL-Y&author=Zhuang%2CS-M generate?
- What's the monthly money flow for https://doi.org/10.1038%2Fnri3790?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Clinical%20blockade%20of%20PD1%20and%20LAG3%E2%80%94potential%20mechanisms%20of%20action&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fnri3790&volume=15&issue=1&publication_year=2015&author=Nguyen%2CLT&author=Ohashi%2CPS?
- How much does https://doi.org/10.3748%2Fwjg.v17.i28.3322 earn?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Immunostaining%20of%20PD-1%2FPD-Ls%20in%20liver%20tissues%20of%20patients%20with%20hepatitis%20and%20hepatocellular%20carcinoma&journal=WJG&doi=10.3748%2Fwjg.v17.i28.3322&volume=17&issue=28&publication_year=2011&author=Wang%2CB-J&author=Bao%2CJ-J&author=Wang%2CJ-Z&author=Wang%2CY&author=Jiang%2CM&author=Xing%2CM-Y?
- Income figures for https://doi.org/10.4143%2Fcrt.2016.066
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20PD-L1%20and%20PD-L2%20is%20associated%20with%20poor%20prognosis%20in%20patients%20with%20hepatocellular%20carcinoma&journal=Cancer%20Res%20treat&doi=10.4143%2Fcrt.2016.066&volume=49&issue=1&publication_year=2017&author=Jung%2CHI&author=Jeong%2CD&author=Ji%2CS&author=Ahn%2CTS&author=Bae%2CSH&author=Chin%2CS
- How much money does https://doi.org/10.1158%2F1078-0432.CCR-08-1608 generate?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20PD-L1%20significantly%20associates%20with%20tumor%20aggressiveness%20and%20postoperative%20recurrence%20in%20human%20hepatocellular%20carcinoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-1608&volume=15&issue=3&pages=971-979&publication_year=2009&author=Gao%2CQ&author=Wang%2CX-Y&author=Qiu%2CS-J&author=Yamato%2CI&author=Sho%2CM&author=Nakajima%2CY make?
- https://doi.org/10.1136%2Fesmoopen-2018-000455's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=Immunotherapy%20for%20hepatocellular%20carcinoma%3A%20current%20status%20and%20future%20perspectives&journal=ESMO%20open&doi=10.1136%2Fesmoopen-2018-000455&volume=3&issue=Suppl%201&publication_year=2018&author=Okusaka%2CT&author=Ikeda%2CM rake in every month?
- How much revenue does https://doi.org/10.7759/cureus.4083 generate?
- How much income does https://doi.org/10.7759%2Fcureus.4083 have?
- How much income does http://scholar.google.com/scholar_lookup?&title=Favorable%20response%20of%20metastatic%20hepatocellular%20carcinoma%20to%20treatment%20with%20trans-arterial%20radioembolization%20followed%20by%20Sorafenib%20and%20Nivolumab&journal=Cureus&doi=10.7759%2Fcureus.4083&publication_year=2019&author=Adcock%2CCS&author=Puneky%2CLV&author=Campbell%2CGS have?
- What's the financial intake of https://doi.org/10.1016%2FS0140-6736%2817%2931046-2?
- How much does http://scholar.google.com/scholar_lookup?&title=Nivolumab%20in%20patients%20with%20advanced%20hepatocellular%20carcinoma%20%28CheckMate%20040%29%3A%20an%20open-label%2C%20non-comparative%2C%20phase%201%2F2%20dose%20escalation%20and%20expansion%20trial&journal=The%20Lancet&doi=10.1016%2FS0140-6736%2817%2931046-2&volume=389&issue=10088&pages=2492-2502&publication_year=2017&author=El-Khoueiry%2CAB&author=Sangro%2CB&author=Yau%2CT&author=Crocenzi%2CTS&author=Kudo%2CM&author=Hsu%2CC generate monthly?
- How much does https://doi.org/10.1136%2Fgutjnl-2014-307671 net monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Tim-3%20fosters%20HCC%20development%20by%20enhancing%20TGF-%CE%B2-mediated%20alternative%20activation%20of%20macrophages&journal=Gut&doi=10.1136%2Fgutjnl-2014-307671&volume=64&issue=10&pages=1593-1604&publication_year=2015&author=Yan%2CW&author=Liu%2CX&author=Ma%2CH&author=Zhang%2CH&author=Song%2CX&author=Gao%2CL have?
- What's https://doi.org/10.1016%2Fj.bulcan.2018.01.018's gross income?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Blocking%20Tim-3%20or%2Fand%20PD-1%20reverses%20dysfunction%20of%20tumor-infiltrating%20lymphocytes%20in%20HBV-related%20hepatocellular%20carcinoma&journal=Bull%20Cancer&doi=10.1016%2Fj.bulcan.2018.01.018&volume=105&issue=5&pages=493-501&publication_year=2018&author=Liu%2CF&author=Zeng%2CG&author=Zhou%2CS&author=He%2CX&author=Sun%2CN&author=Zhu%2CX?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Critical%20signaling%20pathways%20governing%20hepatocellular%20carcinoma%20behavior%3B%20small%20molecule-based%20approaches&journal=Cancer%20Cell%20Int&doi=10.1186%2Fs12935-021-01924-w&volume=21&issue=1&pages=1-15&publication_year=2021&author=Farzaneh%2CZ&author=Vosough%2CM&author=Agarwal%2CT&author=Farzaneh%2CM earns monthly
- https://doi.org/10.1038%2Fncomms10501 income
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Adaptive%20resistance%20to%20therapeutic%20PD-1%20blockade%20is%20associated%20with%20upregulation%20of%20alternative%20immune%20checkpoints&journal=Nat%20Commun&doi=10.1038%2Fncomms10501&volume=7&issue=1&pages=1-9&publication_year=2016&author=Koyama%2CS&author=Akbay%2CEA&author=Li%2CYY&author=Herter-Sprie%2CGS&author=Buczkowski%2CKA&author=Richards%2CWG?
- What's the total monthly financial gain of https://doi.org/10.1038%2Fs41577-019-0224-6?
- How much income is http://scholar.google.com/scholar_lookup?&title=TIM3%20comes%20of%20age%20as%20an%20inhibitory%20receptor&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fs41577-019-0224-6&volume=20&issue=3&pages=173-185&publication_year=2020&author=Wolf%2CY&author=Anderson%2CAC&author=Kuchroo%2CVK earning monthly?
- Learn how profitable https://doi.org/10.1038%2Fs41388-018-0140-4 is on a monthly basis
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Tumor%20cell-intrinsic%20Tim-3%20promotes%20liver%20cancer%20via%20NF-%CE%BAB%2FIL-6%2FSTAT3%20axis&journal=Oncogene&doi=10.1038%2Fs41388-018-0140-4&volume=37&issue=18&pages=2456-2468&publication_year=2018&author=Zhang%2CH&author=Song%2CY&author=Yang%2CH&author=Liu%2CZ&author=Gao%2CL&author=Liang%2CX?
- What's the income of https://doi.org/10.3390%2Fcancers13061440?
- How much does http://scholar.google.com/scholar_lookup?&title=CTLA-4%20in%20regulatory%20T%20cells%20for%20cancer%20immunotherapy&journal=Cancers&doi=10.3390%2Fcancers13061440&volume=13&issue=6&publication_year=2021&author=Sobhani%2CN&author=Tardiel-Cyril%2CDR&author=Davtyan%2CA&author=Generali%2CD&author=Roudi%2CR&author=Li%2CY earn?
- Discover the revenue of https://doi.org/10.1002%2Fhep.26694
- How much does http://scholar.google.com/scholar_lookup?&title=Human%20CD14%2B%20CTLA-4%2B%20regulatory%20dendritic%20cells%20suppress%20T-cell%20response%20by%20cytotoxic%20T-lymphocyte%20antigen-4-dependent%20IL-10%20and%20indoleamine-2%2C%203-dioxygenase%20production%20in%20hepatocellular%20carcinoma&journal=Hepatology&doi=10.1002%2Fhep.26694&volume=59&issue=2&pages=567-579&publication_year=2014&author=Han%2CY&author=Chen%2CZ&author=Yang%2CY&author=Jiang%2CZ&author=Gu%2CY&author=Liu%2CY bring in each month?
- Check the income stats for https://doi.org/10.1016%2Fj.jhep.2013.02.022
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20clinical%20trial%20of%20CTLA-4%20blockade%20with%20tremelimumab%20in%20patients%20with%20hepatocellular%20carcinoma%20and%20chronic%20hepatitis%20C&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2013.02.022&volume=59&issue=1&pages=81-88&publication_year=2013&author=Sangro%2CB&author=Gomez-Martin%2CC&author=Mata%2CM&author=I%C3%B1arrairaegui%2CM&author=Garralda%2CE&author=Barrera%2CP produce monthly?
- Find out how much https://doi.org/10.1200/JCO.2019.37.15_suppl.4012 earns monthly
- Get to know https://doi.org/10.1200%2FJCO.2019.37.15_suppl.4012's earnings
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Nivolumab%20%28NIVO%29%2B%20ipilimumab%20%28IPI%29%20combination%20therapy%20in%20patients%20%28pts%29%20with%20advanced%20hepatocellular%20carcinoma%20%28aHCC%29%3A%20results%20from%20CheckMate%20040&journal=Am%20Soc%20Clin%20Oncol&doi=10.1200%2FJCO.2019.37.15_suppl.4012&publication_year=2019&author=Yau%2CT&author=Kang%2CY-K&author=Kim%2CT-Y&author=El-Khoueiry%2CAB&author=Santoro%2CA&author=Sangro%2CB each month?
- https://doi.org/10.1016%2Fj.jhep.2016.10.029's total income per month
- See how much http://scholar.google.com/scholar_lookup?&title=Tremelimumab%20in%20combination%20with%20ablation%20in%20patients%20with%20advanced%20hepatocellular%20carcinoma&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2016.10.029&volume=66&issue=3&pages=545-551&publication_year=2017&author=Duffy%2CAG&author=Ulahannan%2CSV&author=Makorova-Rusher%2CO&author=Rahma%2CO&author=Wedemeyer%2CH&author=Pratt%2CD makes per month
- What's the income generated by https://doi.org/10.1002%2Fhep.29798 each month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Basolateral%20CD147%20induces%20hepatocyte%20polarity%20loss%20by%20E-cadherin%20ubiquitination%20and%20degradation%20in%20hepatocellular%20carcinoma%20progress&journal=Hepatology&doi=10.1002%2Fhep.29798&volume=68&issue=1&pages=317-332&publication_year=2018&author=Lu%2CM&author=Wu%2CJ&author=Hao%2CZW&author=Shang%2CYK&author=Xu%2CJ&author=Nan%2CG
- How much does https://doi.org/10.1038%2Fonc.2011.149 pull in monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=HAb18G%2FCD147%20promotes%20epithelial%E2%80%93mesenchymal%20transition%20through%20TGF-%CE%B2%20signaling%20and%20is%20transcriptionally%20regulated%20by%20Slug&journal=Oncogene&doi=10.1038%2Fonc.2011.149&volume=30&issue=43&publication_year=2011&author=Wu%2CJ&author=Ru%2CN&author=Zhang%2CY&author=Li%2CY&author=Wei%2CD&author=Ren%2CZ net monthly?
- What is the monthly revenue of https://doi.org/10.1016%2Fj.jhep.2014.04.035?
- http://scholar.google.com/scholar_lookup?&title=CD147%20promotes%20reprogramming%20of%20glucose%20metabolism%20and%20cell%20proliferation%20in%20HCC%20cells%20by%20inhibiting%20the%20p53-dependent%20signaling%20pathway&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2014.04.035&volume=61&issue=4&pages=859-866&publication_year=2014&author=Huang%2CQ&author=Li%2CJ&author=Xing%2CJ&author=Li%2CW&author=Li%2CH&author=Ke%2CX's total income per month
- What's the profit of https://doi.org/10.1016%2Fj.jhep.2015.07.039?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=CD147%20reprograms%20fatty%20acid%20metabolism%20in%20hepatocellular%20carcinoma%20cells%20through%20Akt%2FmTOR%2FSREBP1c%20and%20P38%2FPPAR%CE%B1%20pathways&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2015.07.039&volume=63&issue=6&pages=1378-1389&publication_year=2015&author=Li%2CJ&author=Huang%2CQ&author=Long%2CX&author=Zhang%2CJ&author=Huang%2CX&author=Aa%2CJ?
- How much does https://doi.org/10.21037%2Ftcr.2016.06.28 earn?
- How much income does http://scholar.google.com/scholar_lookup?&title=CD147%20handles%20lipid%3A%20a%20new%20role%20for%20anti-cancer%20target&journal=Transl%20Cancer%20Res&doi=10.21037%2Ftcr.2016.06.28&volume=5&issue=3&pages=238-240&publication_year=2016&author=Felmlee%2CDJ&author=Baumert%2CTF have?
- How much does https://doi.org/10.21147%2Fj.issn.1000-9604.2016.03.14 rake in every month?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Making%20cancer%20fat%3A%20reprogramming%20of%20lipid%20metabolism%20by%20CD147%20in%20hepatocellular%20carcinoma&journal=Chin%20J%20Cancer%20Res&doi=10.21147%2Fj.issn.1000-9604.2016.03.14&volume=28&issue=3&publication_year=2016&author=Ju%2CH-L&author=Ro%2CSW is on a monthly basis
- How much cash flow does https://doi.org/10.3892%2Fetm.2017.4818 have monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20CD147%20is%20associated%20with%20poor%20prognosis%2C%20tumor%20cell%20migration%20and%20ERK%20signaling%20pathway%20activation%20in%20hepatocellular%20carcinoma&journal=Exp%20Ther%20Med&doi=10.3892%2Fetm.2017.4818&volume=14&issue=3&pages=2637-2642&publication_year=2017&author=Xiao%2CW&author=Zhao%2CS&author=Shen%2CF&author=Liang%2CJ&author=Chen%2CJ earning monthly?
- How much money does https://doi.org/10.1093%2Fjnci%2Fdju239 make?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Randomized%20trial%20of%20%5B131I%5D%20metuximab%20in%20treatment%20of%20hepatocellular%20carcinoma%20after%20percutaneous%20radiofrequency%20ablation&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdju239&volume=106&issue=9&publication_year=2014&author=Bian%2CH&author=Zheng%2CJ-S&author=Nan%2CG&author=Li%2CR&author=Chen%2CC&author=Hu%2CC-X
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=A%20chimeric%20antibody%20targeting%20CD147%20inhibits%20hepatocellular%20carcinoma%20cell%20motility%20via%20FAK-PI3K-Akt-Girdin%20signaling%20pathway&journal=Clin%20Exp%20Metastasis&doi=10.1007%2Fs10585-014-9689-7&volume=32&issue=1&pages=39-53&publication_year=2015&author=Wang%2CY&author=Yuan%2CL&author=Yang%2CX-M&author=Wei%2CD&author=Wang%2CB&author=Sun%2CX-X have monthly?
- What's the income of https://doi.org/10.1080%2F13102818.2018.1475254?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Combination%20of%20131I-anti-endoglin%20monoclonal%20antibody%20and%205-fluorouracil%20may%20be%20a%20promising%20combined-modality%20radioimmunotherapy%20strategy%20for%20the%20treatment%20of%20hepatocellular%20carcinoma&journal=Biotechnol%20Biotechnol%20Equip&doi=10.1080%2F13102818.2018.1475254&volume=32&issue=4&pages=974-981&publication_year=2018&author=Duan%2CC&author=Li%2CY&author=Yang%2CW&author=Zhang%2CC
- How much money does https://doi.org/10.3390%2Fijms19123887 make?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Role%20of%20Endoglin%20%28CD105%29%20in%20the%20progression%20of%20hepatocellular%20carcinoma%20and%20anti-angiogenic%20therapy&journal=Int%20J%20Mol%20Sci&doi=10.3390%2Fijms19123887&volume=9&issue=12&publication_year=2018&author=Kasprzak%2CA&author=Adamek%2CA?
- What's the financial gain of https://doi.org/10.1089%2Fcell.2015.0085?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Muse%20cells%2C%20a%20new%20type%20of%20pluripotent%20stem%20cell%20derived%20from%20human%20fibroblasts&journal=Cell%20Reprogram&doi=10.1089%2Fcell.2015.0085&volume=18&issue=2&pages=67-77&publication_year=2016&author=Liu%2CQ&author=Zhang%2CR-Z&author=Li%2CD&author=Cheng%2CS&author=Yang%2CY-H&author=Tian%2CT?
- Revenue of https://doi.org/10.1155/2017/2679518
- How much does https://doi.org/10.1155%2F2017%2F2679518 bring in each month?
- How much money does http://scholar.google.com/scholar_lookup?&title=Immunoprofiling%20of%20adult-derived%20human%20liver%20stem%2Fprogenitor%20cells%3A%20impact%20of%20hepatogenic%20differentiation%20and%20inflammation&journal=Stem%20Cells%20Int&doi=10.1155%2F2017%2F2679518&publication_year=2017&author=El-Kehdy%2CH&author=Sargiacomo%2CC&author=Fayyad-Kazan%2CM&author=Fayyad-Kazan%2CH&author=Lombard%2CC&author=Lagneaux%2CL make?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Rapid%20generation%20of%20functional%20hepatocyte-like%20cells%20from%20human%20adipose-derived%20stem%20cells&journal=Stem%20cell%20Res%20Ther&doi=10.1186%2Fs13287-016-0364-6&volume=7&issue=1&pages=1-12&publication_year=2016&author=Fu%2CY&author=Deng%2CJ&author=Jiang%2CQ&author=Wang%2CY&author=Zhang%2CY&author=Yao%2CY
- What's the financial outcome of https://doi.org/10.1002%2Fterm.2503?
- How much does http://scholar.google.com/scholar_lookup?&title=Hepatic%20perivascular%20mesenchymal%20stem%20cells%20with%20myogenic%20properties&journal=J%20Tissue%20Eng%20Regener%20Med&doi=10.1002%2Fterm.2503&volume=12&issue=3&pages=e1297-e1310&publication_year=2018&author=Shenoy%2CPS&author=Bose%2CB pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=CD105%20promotes%20hepatocarcinoma%20cell%20invasion%20and%20metastasis%20through%20VEGF&journal=Tumor%20Biol&doi=10.1007%2Fs13277-014-2686-2&volume=36&issue=2&pages=737-745&publication_year=2015&author=Li%2CY&author=Zhai%2CZ&author=Liu%2CD&author=Zhong%2CX&author=Meng%2CX&author=Yang%2CQ net monthly?
- Monthly income for https://doi.org/10.1038%2Fonc.2013.5
- How much profit does http://scholar.google.com/scholar_lookup?&title=Thyroid%20hormone%20suppresses%20cell%20proliferation%20through%20endoglin-mediated%20promotion%20of%20p21%20stability&journal=Oncogene&doi=10.1038%2Fonc.2013.5&volume=32&issue=33&pages=3904-3914&publication_year=2013&author=Lin%2CY&author=Huang%2CY&author=Wu%2CM&author=Wu%2CS&author=Chi%2CH&author=Liao%2CC make?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=In%20vitro%20and%20in%20vivo%20effects%20of%20an%20anti-mouse%20endoglin%20%28CD105%29%E2%80%93immunotoxin%20on%20the%20early%20stages%20of%20mouse%20B16MEL4A5%20melanoma%20tumours&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-012-1357-7&volume=62&issue=3&pages=541-551&publication_year=2013&author=Mu%C3%B1oz%2CR&author=Arias%2CY&author=Ferreras%2CJM&author=Jim%C3%A9nez%2CP&author=Langa%2CC&author=Rojo%2CMA?
- Learn about the earnings of https://doi.org/10.1016%2Fj.bbagen.2018.03.012
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Endoglin%20based%20in%20vivo%20near-infrared%20fluorescence%20imaging%20of%20tumor%20models%20in%20mice%20using%20activatable%20liposomes&journal=Biochim%20Biophys%20Acta&doi=10.1016%2Fj.bbagen.2018.03.012&volume=1862&issue=6&pages=1389-1400&publication_year=2018&author=Tansi%2CFL&author=R%C3%BCger%2CR&author=Kollmeier%2CAM&author=Rabenhold%2CM&author=Steiniger%2CF&author=Kontermann%2CRE?
- How much profit is https://doi.org/10.1038%2Fnrc3005 making per month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Novel%20roles%20for%20Slits%20and%20netrins%3A%20axon%20guidance%20cues%20as%20anticancer%20targets%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc3005&volume=11&issue=3&pages=188-197&publication_year=2011&author=Mehlen%2CP&author=Delloye-Bourgeois%2CC&author=Ch%C3%A9dotal%2CA?
- How much money does http://scholar.google.com/scholar_lookup?&title=ROBO1%20promotes%20angiogenesis%20in%20hepatocellular%20carcinoma%20through%20the%20Rho%20family%20of%20guanosine%20triphosphatases%E2%80%99%20signaling%20pathway&journal=Tumor%20Biol&doi=10.1007%2Fs13277-015-3601-1&volume=36&issue=11&pages=8413-8424&publication_year=2015&author=Ao%2CJ-Y&author=Chai%2CZ-T&author=Zhang%2CY-Y&author=Zhu%2CX-D&author=Kong%2CL-Q&author=Zhang%2CN make?
- What is the earnings of https://doi.org/10.1371%2Fjournal.pgen.1004873?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Systemic%20delivery%20of%20microRNA-101%20potently%20inhibits%20hepatocellular%20carcinoma%20in%20vivo%20by%20repressing%20multiple%20targets&journal=PLoS%20Genet&doi=10.1371%2Fjournal.pgen.1004873&volume=11&issue=2&publication_year=2015&author=Zheng%2CF&author=Liao%2CY-J&author=Cai%2CM-Y&author=Liu%2CT-H&author=Chen%2CS-P&author=Wu%2CP-H?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%2090%20Y-labelled%20anti-ROBO1%20monoclonal%20antibody%20exhibits%20antitumour%20activity%20against%20hepatocellular%20carcinoma%20xenografts%20during%20ROBO1-targeted%20radioimmunotherapy&journal=EJNMMI%20Res&doi=10.1186%2Fs13550-014-0029-3&volume=4&issue=1&pages=1-10&publication_year=2014&author=Fujiwara%2CK&author=Koyama%2CK&author=Suga%2CK&author=Ikemura%2CM&author=Saito%2CY&author=Hino%2CA generate?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Cellular%20and%20molecular%20targets%20for%20the%20immunotherapy%20of%20hepatocellular%20carcinoma&journal=Mol%20Cell%20Biochem&doi=10.1007%2Fs11010-017-3092-z&volume=437&issue=1%E2%80%932&pages=13-36&publication_year=2018&author=Rai%2CV&author=Abdo%2CJ&author=Alsuwaidan%2CAN&author=Agrawal%2CS&author=Sharma%2CP&author=Agrawal%2CDK
- What's the monthly money flow for https://doi.org/10.3389%2Ffbioe.2019.00319?
- How much does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20hepatocellular%20carcinoma%20by%20intratumoral%20injection%20of%20125I-AA98%20mAb%20and%20its%20efficacy%20assessments%20by%20molecular%20imaging&journal=Front%20Bioeng%20Biotechnol&doi=10.3389%2Ffbioe.2019.00319&volume=7&publication_year=2019&author=Zhou%2CJ&author=Hu%2CP&author=Si%2CZ&author=Tan%2CH&author=Qiu%2CL&author=Zhang%2CH net monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Tumor%20vascular%20homing%20endgolin-targeted%20radioimmunotherapy%20in%20hepatocellular%20carcinoma&journal=Tumor%20Biol&doi=10.1007%2Fs13277-014-2529-1&volume=35&issue=12&pages=12205-12215&publication_year=2014&author=Duan%2CC-L&author=Hou%2CG-H&author=Liu%2CY-P&author=Liang%2CT&author=Song%2CJ&author=Han%2CJ-K
- Profit of https://doi.org/10.1158%2F0008-5472.CAN-11-3406
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Anti-VEGF%2FVEGFR%20therapy%20for%20cancer%3A%20reassessing%20the%20target&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-11-3406&volume=72&issue=8&pages=1909-1914&publication_year=2012&author=Sitohy%2CB&author=Nagy%2CJA&author=Dvorak%2CHF?
- How much does https://doi.org/10.14218%2FJCTH.2020.00001 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Management%20and%20treatment%20of%20hepatocellular%20carcinoma%20with%20immunotherapy%3A%20a%20review%20of%20current%20and%20future%20options&journal=J%20Clin%20Transl%20Hepatol&doi=10.14218%2FJCTH.2020.00001&volume=8&issue=2&publication_year=2020&author=Ghavimi%2CS&author=Apfel%2CT&author=Azimi%2CH&author=Persaud%2CA&author=Pyrsopoulos%2CNT pull in monthly?
- How much profit does https://doi.org/10.3390%2Fcells8060558 make?
- Revenue of http://scholar.google.com/scholar_lookup?&title=HCC-derived%20exosomes%3A%20critical%20player%20and%20target%20for%20cancer%20immune%20escape&journal=Cells&doi=10.3390%2Fcells8060558&volume=8&issue=6&publication_year=2019&author=Han%2CQ&author=Zhao%2CH&author=Jiang%2CY&author=Yin%2CC&author=Zhang%2CJ
- How much does http://scholar.google.com/scholar_lookup?&title=Downregulation%20of%20exosomal%20CLEC3B%20in%20hepatocellular%20carcinoma%20promotes%20metastasis%20and%20angiogenesis%20via%20AMPK%20and%20VEGF%20signals&journal=Cell%20Commun%20Signal&doi=10.1186%2Fs12964-019-0423-6&volume=17&issue=1&publication_year=2019&author=Dai%2CW&author=Wang%2CY&author=Yang%2CT&author=Wang%2CJ&author=Wu%2CW&author=Gu%2CJ rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20exosomal%20PD-L1%20in%20tumor%20progression%20and%20immunotherapy&journal=Mol%20Cancer&doi=10.1186%2Fs12943-019-1074-3&volume=18&issue=1&publication_year=2019&author=Xie%2CF&author=Xu%2CM&author=Lu%2CJ&author=Mao%2CL&author=Wang%2CS net monthly?
- How much profit is https://doi.org/10.1155/2017/1073947 making per month?
- What are the earnings of https://doi.org/10.1155%2F2017%2F1073947?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-related%20exosomes%20contribute%20to%20tumor-promoting%20microenvironment%3A%20an%20immunological%20perspective&journal=J%20Immunol%20Res&doi=10.1155%2F2017%2F1073947&publication_year=2017&author=Chen%2CW&author=Jiang%2CJ&author=Xia%2CW&author=Huang%2CJ gross monthly?
- How profitable is https://doi.org/10.1155/2020/6272498?
- What's the financial outcome of https://doi.org/10.1155%2F2020%2F6272498?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Tumor-derived%20exosomes%20in%20immunosuppression%20and%20immunotherapy&journal=J%20Immunol%20Res&doi=10.1155%2F2020%2F6272498&publication_year=2020&author=Olejarz%2CW&author=Dominiak%2CA&author=%C5%BBo%C5%82nierzak%2CA&author=Kubiak-Tomaszewska%2CG&author=Lorenc%2CT generate?
- What are the earnings of https://doi.org/10.1016%2Fj.tranon.2018.01.001?
- Get to know http://scholar.google.com/scholar_lookup?&title=Dendritic%20cells%20pulsed%20with%20exosomes%20in%20combination%20with%20PD-1%20antibody%20increase%20the%20efficacy%20of%20Sorafenib%20in%20hepatocellular%20carcinoma%20model&journal=Transl%20Oncol&doi=10.1016%2Fj.tranon.2018.01.001&volume=11&issue=2&pages=250-258&publication_year=2018&author=Shi%2CS&author=Rao%2CQ&author=Zhang%2CC&author=Zhang%2CX&author=Qin%2CY&author=Niu%2CZ's earnings
- What's the revenue for https://doi.org/10.1002%2Fhep.28549?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor-derived%20exosomes%20elicit%20tumor%20suppression%20in%20murine%20hepatocellular%20carcinoma%20models%20and%20humans%20in%20vitro&journal=Hepatology&doi=10.1002%2Fhep.28549&volume=64&issue=2&pages=456-472&publication_year=2016&author=Rao%2CQ&author=Zuo%2CB&author=Lu%2CZ&author=Gao%2CX&author=You%2CA&author=Wu%2CC bring in each month?
- How much profit does https://doi.org/10.1016%2Fj.yjmcc.2015.12.028 make?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Exosomes%20derived%20from%20dendritic%20cells%20improve%20cardiac%20function%20via%20activation%20of%20CD4%2B%20T%20lymphocytes%20after%20myocardial%20infarction&journal=J%20Mol%20Cell%20Cardiol&doi=10.1016%2Fj.yjmcc.2015.12.028&volume=91&pages=123-133&publication_year=2016&author=Liu%2CH&author=Gao%2CW&author=Yuan%2CJ&author=Wu%2CC&author=Yao%2CK&author=Zhang%2CL?
- What is the monthly revenue of https://doi.org/10.1038%2Fnature14011?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Predictive%20correlates%20of%20response%20to%20the%20anti-PD-L1%20antibody%20MPDL3280A%20in%20cancer%20patients&journal=Nature&doi=10.1038%2Fnature14011&volume=515&issue=7528&pages=563-567&publication_year=2014&author=Herbst%2CRS&author=Soria%2CJ-C&author=Kowanetz%2CM&author=Fine%2CGD&author=Hamid%2CO&author=Gordon%2CMS?
- Income figures for https://doi.org/10.3390%2Fijms20061406
- How much does http://scholar.google.com/scholar_lookup?&title=Exosomes%20and%20hepatocellular%20carcinoma%3A%20from%20bench%20to%20bedside&journal=Int%20J%20Mol%20Sci&doi=10.3390%2Fijms20061406&volume=20&issue=6&publication_year=2019&author=Sasaki%2CR&author=Kanda%2CT&author=Yokosuka%2CO&author=Kato%2CN&author=Matsuoka%2CS&author=Moriyama%2CM rake in every month?
- What's http://scholar.google.com/scholar_lookup?&title=Endoplasmic%20reticulum%20stress%20causes%20liver%20cancer%20cells%20to%20release%20exosomal%20miR-23a-3p%20and%20up-regulate%20programmed%20death%20ligand%201%20expression%20in%20macrophages&journal=Hepatology&volume=70&issue=1&pages=241-258&publication_year=2019&author=Liu%2CJ&author=Fan%2CL&author=Yu%2CH&author=Zhang%2CJ&author=He%2CY&author=Feng%2CD's gross income?
- How much profit is https://doi.org/10.7150%2Fijbs.19642 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Exosomes%20from%20melatonin%20treated%20hepatocellularcarcinoma%20cells%20alter%20the%20immunosupression%20status%20through%20STAT3%20pathway%20in%20macrophages&journal=Int%20J%20Biol%20Sci&doi=10.7150%2Fijbs.19642&volume=13&issue=6&pages=723-734&publication_year=2017&author=Cheng%2CL&author=Liu%2CJ&author=Liu%2CQ&author=Liu%2CY&author=Fan%2CL&author=Wang%2CF earn?
- How much cash flow does https://doi.org/10.1038%2Fs41598-019-47235-z have monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Circulating%20levels%20of%20PD-L1%20and%20Galectin-9%20are%20associated%20with%20patient%20survival%20in%20surgically%20treated%20Hepatocellular%20Carcinoma%20independent%20of%20their%20intra-tumoral%20expression%20levels&journal=Sci%20Rep&doi=10.1038%2Fs41598-019-47235-z&volume=9&issue=1&pages=1-10&publication_year=2019&author=Sideras%2CK&author=Robert%2CA&author=Harrington%2CSM&author=Polak%2CWG&author=Zhou%2CG&author=Schutz%2CHM?
- What's the financial gain of https://doi.org/10.1016%2Fj.jhep.2017.05.019?
- Get to know http://scholar.google.com/scholar_lookup?&title=Dendritic%20cell-derived%20exosomes%20elicit%20tumor%20regression%20in%20autochthonous%20hepatocellular%20carcinoma%20mouse%20models&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2017.05.019&volume=67&issue=4&pages=739-748&publication_year=2017&author=Lu%2CZ&author=Zuo%2CB&author=Jing%2CR&author=Gao%2CX&author=Rao%2CQ&author=Liu%2CZ's earnings
- How much does https://doi.org/10.2147%2FOTT.S209413 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Exosomes%20derived%20from%20HCC%20cells%20with%20different%20invasion%20characteristics%20mediated%20EMT%20through%20TGF-%CE%B2%2FSmad%20signaling%20pathway&journal=OncoTargets%20Ther&doi=10.2147%2FOTT.S209413&volume=12&publication_year=2019&author=Qu%2CZ&author=Feng%2CJ&author=Pan%2CH&author=Jiang%2CY&author=Duan%2CY&author=Fa%2CZJO generate monthly?
- What's the financial intake of https://doi.org/10.1016%2Fj.canlet.2020.02.003?
- http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma-derived%20exosomes%20in%20organotropic%20metastasis%2C%20recurrence%20and%20early%20diagnosis%20application&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2020.02.003&volume=477&pages=41-48&publication_year=2020&author=Ge%2CY&author=Mu%2CW&author=Ba%2CQ&author=Li%2CJ&author=Jiang%2CY&author=Xia%2CQ's financial summary
- How much income is https://doi.org/10.3389%2Ffonc.2014.00361 earning monthly?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20exosomes%20in%20epithelial%E2%80%93mesenchymal-transition%20in%20cancer&journal=Front%20Oncol&doi=10.3389%2Ffonc.2014.00361&volume=4&publication_year=2014&author=Vella%2CL?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Exosome%20delivered%20anticancer%20drugs%20across%20the%20blood-brain%20barrier%20for%20brain%20cancer%20therapy%20in%20Danio%20rerio&journal=Pharm%20Res&doi=10.1007%2Fs11095-014-1593-y&volume=32&issue=6&pages=2003-2014&publication_year=2015&author=Yang%2CT&author=Martin%2CP&author=Fogarty%2CB&author=Brown%2CA&author=Schurman%2CK&author=Phipps%2CR have monthly?
- What's the profit of https://doi.org/10.1016%2Fj.apsb.2016.02.001?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Exosomes%20as%20therapeutic%20drug%20carriers%20and%20delivery%20vehicles%20across%20biological%20membranes%3A%20current%20perspectives%20and%20future%20challenges&journal=Acta%20Pharm%20Sin&doi=10.1016%2Fj.apsb.2016.02.001&volume=6&issue=4&pages=287-296&publication_year=2016&author=Ha%2CD&author=Yang%2CN&author=Nadithe%2CV?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=A%20comprehensive%20overview%20of%20exosomes%20as%20drug%20delivery%20vehicles%E2%80%94endogenous%20nanocarriers%20for%20targeted%20cancer%20therapy&journal=Biochim%20Biophys%20Acta&volume=1846&issue=1&pages=75-87&publication_year=2014&author=Johnsen%2CKB&author=Gudbergsson%2CJM&author=Skov%2CMN&author=Pilgaard%2CL&author=Moos%2CT&author=Duroux%2CM
- Monthly income for https://doi.org/10.1002%2Fhep.29586
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Exosome%20miR-335%20as%20a%20novel%20therapeutic%20strategy%20in%20hepatocellular%20carcinoma&journal=Hepatology&doi=10.1002%2Fhep.29586&volume=67&issue=3&pages=940-954&publication_year=2018&author=Wang%2CF&author=Li%2CL&author=Piontek%2CK&author=Sakaguchi%2CM&author=Selaru%2CFM?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Exosomes%20derived%20from%20miR-122-modified%20adipose%20tissue-derived%20MSCs%20increase%20chemosensitivity%20of%20hepatocellular%20carcinoma&journal=J%20Hematol%20Oncol&doi=10.1186%2Fs13045-015-0220-7&volume=8&issue=1&pages=1-11&publication_year=2015&author=Lou%2CG&author=Song%2CX&author=Yang%2CF&author=Wu%2CS&author=Wang%2CJ&author=Chen%2CZ
- Find out how much http://scholar.google.com/scholar_lookup?&title=MiR-199a-modified%20exosomes%20from%20adipose%20tissue-derived%20mesenchymal%20stem%20cells%20improve%20hepatocellular%20carcinoma%20chemosensitivity%20through%20mTOR%20pathway&journal=J%20Exp%20Clin%20Cancer%20Res&doi=10.1186%2Fs13046-019-1512-5&volume=39&issue=1&publication_year=2020&author=Lou%2CG&author=Chen%2CL&author=Xia%2CC&author=Wang%2CW&author=Qi%2CJ&author=Li%2CA earns monthly
- How much profit is https://doi.org/10.3390%2Fcancers11020179 making per month?
- See how much http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20tetraspanins%20with%20monoclonal%20antibodies%20in%20oncology%3A%20focus%20on%20Tspan8%2FCo-029&journal=Cancers&doi=10.3390%2Fcancers11020179&volume=11&issue=2&publication_year=2019&author=Bonnet%2CM&author=Maisonial-Besset%2CA&author=Zhu%2CY&author=Witkowski%2CT&author=Roche%2CG&author=Boucheix%2CC makes per month
- How much revenue does https://doi.org/10.18632%2Foncotarget.9769 bring in?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Tetraspanin-8%20promotes%20hepatocellular%20carcinoma%20metastasis%20by%20increasing%20ADAM12m%20expression&journal=Oncotarget&doi=10.18632%2Foncotarget.9769&volume=7&issue=26&publication_year=2016&author=Fang%2CT&author=Lin%2CJ&author=Wang%2CY&author=Chen%2CG&author=Huang%2CJ&author=Chen%2CJ?
- What's the revenue for https://doi.org/10.1089%2Fdna.2011.1264?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20S100B%2C%20TM4SF4%2C%20and%20OLFM4%20genes%20is%20correlated%20with%20liver%20metastasis%20in%20Taiwanese%20colorectal%20cancer%20patients&journal=DNA%20Cell%20Biol&doi=10.1089%2Fdna.2011.1264&volume=31&issue=1&pages=43-49&publication_year=2012&author=Huang%2CM-Y&author=Wang%2CH-M&author=Chang%2CH-J&author=Hsiao%2CC-P&author=Wang%2CJ-Y&author=Lin%2CS-RJD is on a monthly basis
- Explore the financials of https://doi.org/10.18632%2Foncotarget.2958
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20tetraspanins%20CD151%20and%20Tspan8%20are%20essential%20exosome%20components%20for%20the%20crosstalk%20between%20cancer%20initiating%20cells%20and%20their%20surrounding&journal=Oncotarget&doi=10.18632%2Foncotarget.2958&volume=6&issue=4&publication_year=2015&author=Yue%2CS&author=Mu%2CW&author=Erb%2CU&author=Z%C3%B6ller%2CM have?
- Get to know what's the income of https://doi.org/10.1016%2Fj.addr.2020.04.004
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Extracellular%20vesicles%20as%20drug%20delivery%20systems%3A%20why%20and%20how%3F&journal=Adv%20Drug%20Deliv%20Rev&doi=10.1016%2Fj.addr.2020.04.004&volume=159&pages=332-343&publication_year=2020&author=Elsharkasy%2COM&author=Nordin%2CJZ&author=Hagey%2CDW&author=Jong%2COG&author=Schiffelers%2CRM&author=Andaloussi%2CSE
- Financial intake of https://doi.org/10.1038%2Fs41565-021-00931-2
- http://scholar.google.com/scholar_lookup?&title=Extracellular%20vesicles%20as%20a%20next-generation%20drug%20delivery%20platform&journal=Nat%20Nanotechnol&doi=10.1038%2Fs41565-021-00931-2&volume=16&issue=7&pages=748-759&publication_year=2021&author=Herrmann%2CIK&author=Wood%2CMJA&author=Fuhrmann%2CG income
- How much does https://doi.org/10.3390%2Fcells9071601 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Extracellular%20vesicles%20as%20delivery%20vehicles%20of%20specific%20cellular%20cargo&journal=Cells&doi=10.3390%2Fcells9071601&volume=9&issue=7&publication_year=2020&author=Mir%2CB&author=Goettsch%2CC gross monthly?
- How much revenue does https://doi.org/10.1016%2FS1470-2045%2817%2930683-6 bring in?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20selective%20internal%20radiotherapy%20with%20yttrium-90%20resin%20microspheres%20compared%20with%20sorafenib%20in%20locally%20advanced%20and%20inoperable%20hepatocellular%20carcinoma%20%28SARAH%29%3A%20an%20open-label%20randomised%20controlled%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2817%2930683-6&volume=18&issue=12&pages=1624-1636&publication_year=2017&author=Vilgrain%2CV&author=Pereira%2CH&author=Assenat%2CE&author=Guiu%2CB&author=Ilonca%2CAD&author=Pageaux%2CG-P
- https://doi.org/10.1111%2Fhepr.13191's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20blockade%20for%20the%20treatment%20of%20human%20hepatocellular%20carcinoma&journal=Hepatol%20Res&doi=10.1111%2Fhepr.13191&volume=48&issue=8&pages=622-634&publication_year=2018&author=Nishida%2CN&author=Kudo%2CM rake in every month?
- https://doi.org/10.1016%2FS1470-2045%2815%2900198-9's revenue stream
- How much money does http://scholar.google.com/scholar_lookup?&title=Adjuvant%20sorafenib%20for%20hepatocellular%20carcinoma%20after%20resection%20or%20ablation%20%28STORM%29%3A%20a%20phase%203%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2815%2900198-9&volume=16&issue=13&pages=1344-1354&publication_year=2015&author=Bruix%2CJ&author=Takayama%2CT&author=Mazzaferro%2CV&author=Chau%2CG-Y&author=Yang%2CJ&author=Kudo%2CM generate?
- Financial intake of https://doi.org/10.1038%2Fs41586-018-0392-8
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Exosomal%20PD-L1%20contributes%20to%20immunosuppression%20and%20is%20associated%20with%20anti-PD-1%20response&journal=Nature&doi=10.1038%2Fs41586-018-0392-8&volume=560&issue=7718&pages=382-386&publication_year=2018&author=Chen%2CG&author=Huang%2CAC&author=Zhang%2CW&author=Zhang%2CG&author=Wu%2CM&author=Xu%2CW
- How much income does https://doi.org/10.1200%2FJCO.2015.65.9789 have?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Nivolumab%20in%20patients%20with%20relapsed%20or%20refractory%20hematologic%20malignancy%3A%20preliminary%20results%20of%20a%20phase%20Ib%20study&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2015.65.9789&volume=34&issue=23&publication_year=2016&author=Lesokhin%2CAM&author=Ansell%2CSM&author=Armand%2CP&author=Scott%2CEC&author=Halwani%2CA&author=Gutierrez%2CM earns monthly
- Profit of https://doi.org/10.1016%2FS1470-2045%2817%2930104-3
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Nivolumab%20for%20previously%20treated%20unresectable%20metastatic%20anal%20cancer%20%28NCI9673%29%3A%20a%20multicentre%2C%20single-arm%2C%20phase%202%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2817%2930104-3&volume=18&issue=4&pages=446-453&publication_year=2017&author=Morris%2CVK&author=Salem%2CME&author=Nimeiri%2CH&author=Iqbal%2CS&author=Singh%2CP&author=Ciombor%2CK?
- Discover the revenue of https://doi.org/10.1159%2F000449342
- How much income is http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20blockade%20in%20hepatocellular%20carcinoma%3A%202017%20update&journal=Liver%20Cancer&doi=10.1159%2F000449342&volume=6&issue=1&pages=1-12&publication_year=2017&author=Kudo%2CM earning monthly?
- https://doi.org/10.2147%2FJHC.S187121 income
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=The%20immune%20modulation%20effect%20of%20locoregional%20therapies%20and%20its%20potential%20synergy%20with%20immunotherapy%20in%20hepatocellular%20carcinoma&journal=J%20Hepatocell%20Carcinoma&doi=10.2147%2FJHC.S187121&volume=7&publication_year=2020&author=Singh%2CP&author=Toom%2CS&author=Avula%2CA&author=Kumar%2CV&author=Rahma%2COE?
- How much revenue does https://doi.org/10.3390%2Fmedicina55100698 produce monthly?
- http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20immune%20checkpoint%20inhibitors%20in%20hepatocellular%20carcinoma&journal=Medicina&doi=10.3390%2Fmedicina55100698&volume=55&issue=10&publication_year=2019&author=Longo%2CV&author=Brunetti%2CO&author=Gnoni%2CA&author=Licchetta%2CA&author=Delcuratolo%2CS&author=Memeo%2CR income
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-18-2484?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Anti-PD-1%20antibody%20SHR-1210%20combined%20with%20apatinib%20for%20advanced%20hepatocellular%20carcinoma%2C%20gastric%2C%20or%20esophagogastric%20junction%20cancer%3A%20an%20open-label%2C%20dose%20escalation%20and%20expansion%20study&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-18-2484&volume=25&issue=2&pages=515-523&publication_year=2019&author=Xu%2CJ&author=Zhang%2CY&author=Jia%2CR&author=Yue%2CC&author=Chang%2CL&author=Liu%2CR?
- https://doi.org/10.1159%2F000486487's revenue stream
- http://scholar.google.com/scholar_lookup?&title=Combination%20cancer%20immunotherapy%20in%20hepatocellular%20carcinoma&journal=Liver%20Cancer&doi=10.1159%2F000486487&volume=7&issue=1&publication_year=2018&author=Kudo%2CM's financial summary
- What's the income of https://doi.org/10.18632%2Foncotarget.26893?
- What's http://scholar.google.com/scholar_lookup?&title=Phase%20I%20study%20of%20local%20radiation%20and%20tremelimumab%20in%20patients%20with%20inoperable%20locally%20recurrent%20or%20metastatic%20breast%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.26893&volume=10&issue=31&publication_year=2019&author=Maria%20Jiang%2CAF&author=Nguyen%2CLT&author=Neel%2CBG&author=Sacher%2CA&author=Rottapel%2CR&author=Wang%2CBX's gross income?
- Find out how much https://doi.org/10.1016%2FS2468-1253%2819%2930422-4 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Adjuvant%20131I-metuximab%20for%20hepatocellular%20carcinoma%20after%20liver%20resection%3A%20a%20randomised%2C%20controlled%2C%20multicentre%2C%20open-label%2C%20phase%202%20trial&journal=Lancet%20Gastroenterol%20Hepatol&doi=10.1016%2FS2468-1253%2819%2930422-4&volume=5&issue=6&pages=548-560&publication_year=2020&author=Li%2CJ&author=Xing%2CJ&author=Yang%2CY&author=Liu%2CJ&author=Wang%2CW&author=Xia%2CY's financial summary
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20licartin%20combined%20with%20pirarubicin%20TACE%20on%20apoptosis%20and%20epithelial-mesenchymal%20transition%20in%20unresectable%20liver%20cancer%20tissue&journal=J%20Hainan%20Med%20Univ&volume=24&issue=2&pages=111-114&publication_year=2018&author=Zhang%2CJ-C&author=Tian%2CY-Y&author=Yang%2CC&author=Ma%2CJ-P&author=Jiang%2CF-Q&author=Yang%2CJ
- Learn how profitable https://doi.org/10.1111%2Fbju.12986 is on a monthly basis
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20TRC%20105%20anti-endoglin%20%28CD%20105%29%20antibody%20in%20metastatic%20castration-resistant%20prostate%20cancer&journal=BJU%20Int&doi=10.1111%2Fbju.12986&volume=116&issue=4&pages=546-555&publication_year=2015&author=Karzai%2CFH&author=Apolo%2CAB&author=Cao%2CL&author=Madan%2CRA&author=Adelberg%2CDE&author=Parnes%2CH have monthly?
- What's the income of https://doi.org/10.1158%2F1078-0432.CCR-14-1143?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=An%20open-label%20phase%20Ib%20dose-escalation%20study%20of%20TRC105%20%28anti-endoglin%20antibody%29%20with%20bevacizumab%20in%20patients%20with%20advanced%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-1143&volume=20&issue=23&pages=5918-5926&publication_year=2014&author=Gordon%2CMS&author=Robert%2CF&author=Matei%2CD&author=Mendelson%2CDS&author=Goldman%2CJW&author=Chiorean%2CEG?
- Financial intake of https://doi.org/10.1177%2F2050640615583587
- Revenue of http://scholar.google.com/scholar_lookup?&title=A%20phase%20II%20study%20of%20TRC105%20in%20patients%20with%20hepatocellular%20carcinoma%20who%20have%20progressed%20on%20sorafenib&journal=U%20Eur%20Gastroenterol%20J&doi=10.1177%2F2050640615583587&volume=3&issue=5&pages=453-461&publication_year=2015&author=Duffy%2CA&author=Ulahannan%2CS&author=Cao%2CL&author=Rahma%2CO&author=Makarova-Rusher%2CO&author=Kleiner%2CD
- Learn how profitable https://doi.org/10.1016%2Fj.intimp.2021.108322 is on a monthly basis
- http://scholar.google.com/scholar_lookup?&title=Immunotherapeutic%20treatments%20in%20hepatocellular%20carcinoma%3B%20achievements%2C%20challenges%20and%20future%20prospects&journal=Int%20Immunopharmacol&doi=10.1016%2Fj.intimp.2021.108322&volume=101&publication_year=2021&author=Roudi%2CR&author=D%27Angelo%2CA&author=Sirico%2CM&author=Sobhani%2CN income
- How much does https://doi.org/10.1016%2FS1470-2045%2818%2930351-6 net monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20in%20patients%20with%20advanced%20hepatocellular%20carcinoma%20previously%20treated%20with%20sorafenib%20%28KEYNOTE-224%29%3A%20a%20non-randomised%2C%20open-label%20phase%202%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930351-6&volume=19&issue=7&pages=940-952&publication_year=2018&author=Zhu%2CAX&author=Finn%2CRS&author=Edeline%2CJ&author=Cattan%2CS&author=Ogasawara%2CS&author=Palmer%2CD
- Monthly income for https://doi.org/10.3389%2Ffimmu.2020.01037
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Anti%E2%80%93PD-1%2FPD-L1%20blockade%20immunotherapy%20employed%20in%20treating%20hepatitis%20B%20virus%20infection%E2%80%93related%20advanced%20hepatocellular%20carcinoma%3A%20a%20literature%20review&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2020.01037&volume=11&publication_year=2020&author=Li%2CB&author=Yan%2CC&author=Zhu%2CJ&author=Chen%2CX&author=Fu%2CQ&author=Zhang%2CH?
- See how much https://doi.org/10.1038%2Fs41586-021-03362-0 makes per month
- How much does http://scholar.google.com/scholar_lookup?&title=NASH%20limits%20anti-tumour%20surveillance%20in%20immunotherapy-treated%20HCC&journal=Nature&doi=10.1038%2Fs41586-021-03362-0&volume=592&issue=7854&pages=450-456&publication_year=2021&author=Pfister%2CD&author=N%C3%BA%C3%B1ez%2CNG&author=Pinyol%2CR&author=Govaere%2CO&author=Pinter%2CM&author=Szydlowska%2CM earn?
- Profit of https://doi.org/10.21037%2Fjgo.2017.06.08
- Profit of http://scholar.google.com/scholar_lookup?&title=Immunomodulation%20in%20hepatocellular%20cancer&journal=J%20Gastrointest%20Oncol&doi=10.21037%2Fjgo.2017.06.08&volume=9&issue=1&publication_year=2018&author=Lee%2CS&author=Loecher%2CM&author=Iyer%2CR
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Current%20perspectives%20on%20the%20immunosuppressive%20tumor%20microenvironment%20in%20hepatocellular%20carcinoma%3A%20challenges%20and%20opportunities&journal=Mol%20Cancer&doi=10.1186%2Fs12943-019-1047-6&volume=18&issue=1&pages=1-12&publication_year=2019&author=Lu%2CC&author=Rong%2CD&author=Zhang%2CB&author=Zheng%2CW&author=Wang%2CX&author=Chen%2CZ
- How much profit does https://doi.org/10.3748%2Fwjg.v25.i20.2416 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=Optimizing%20radiotherapy%20with%20immune%20checkpoint%20blockade%20in%20hepatocellular%20carcinoma&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v25.i20.2416&volume=25&issue=20&publication_year=2019&author=Choi%2CC&author=Yoo%2CGS&author=Cho%2CWK&author=Park%2CHC make?
- How much does https://doi.org/10.1016%2Fj.drup.2019.07.004 bring in each month?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20inhibitor%20combinations%3A%20current%20efforts%20and%20important%20aspects%20for%20success&journal=Drug%20Resist%20Updates&doi=10.1016%2Fj.drup.2019.07.004&volume=45&pages=13-29&publication_year=2019&author=Kon%2CE&author=Benhar%2CI making per month?
- How much income does https://doi.org/10.1093%2Fannonc%2Fmdy495 have?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Development%20of%20tumor%20mutation%20burden%20as%20an%20immunotherapy%20biomarker%3A%20utility%20for%20the%20oncology%20clinic&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdy495&volume=30&issue=1&pages=44-56&publication_year=2019&author=Chan%2CTA&author=Yarchoan%2CM&author=Jaffee%2CE&author=Swanton%2CC&author=Quezada%2CSA&author=Stenzinger%2CA?
- How much does https://doi.org/10.5858%2Farpa.2015-0287-SA earn?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Next-generation%20sequencing%20and%20immunotherapy%20biomarkers%3A%20a%20medical%20oncology%20perspective&journal=Arch%20Pathol%20Lab%20Med&doi=10.5858%2Farpa.2015-0287-SA&volume=140&issue=3&pages=245-248&publication_year=2016&author=Bernicker%2CE have monthly?
- How much profit does https://doi.org/10.1136%2Fesmoopen-2016-000042 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Cancer%20and%20liver%20cirrhosis%3A%20implications%20on%20prognosis%20and%20management&journal=ESMO%20Open&doi=10.1136%2Fesmoopen-2016-000042&volume=1&issue=2&publication_year=2016&author=Pinter%2CM&author=Trauner%2CM&author=Peck-Radosavljevic%2CM&author=Sieghart%2CW?
- How much profit is https://doi.org/10.3389%2Ffimmu.2014.00258 making per month?
- How profitable is http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20natural%20killer%20cells%20and%20CD8%2B%20T%20cells%20in%20hepatitis%20B%20virus%20infection&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2014.00258&volume=5&publication_year=2014&author=Schuch%2CA&author=Hoh%2CA&author=Thimme%2CR?
- What's the monthly money flow for https://doi.org/10.2147%2FJHC.S224471?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Angiogenesis%20in%20hepatocellular%20carcinoma%3B%20pathophysiology%2C%20targeted%20therapy%2C%20and%20role%20of%20imaging&journal=J%20Hepatocell%20Carcinoma&doi=10.2147%2FJHC.S224471&volume=7&publication_year=2020&author=Moawad%2CAW&author=Szklaruk%2CJ&author=Lall%2CC&author=Blair%2CKJ&author=Kaseb%2CAO&author=Kamath%2CA?
- How much does https://doi.org/10.1634%2Ftheoncologist.2019-IO-S1-s01 bring in each month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20inhibitors%20in%20hepatocellular%20carcinoma%3A%20opportunities%20and%20challenges&journal=Oncologist&doi=10.1634%2Ftheoncologist.2019-IO-S1-s01&volume=24&issue=Suppl%201&publication_year=2019&author=Liu%2CX&author=Qin%2CS make?
- What's the income of https://doi.org/10.1159%2F000452138?
- How much money does http://scholar.google.com/scholar_lookup?&title=Molecular%20targeted%20agents%20for%20hepatocellular%20carcinoma%3A%20current%20status%20and%20future%20perspectives&journal=Liver%20Cancer&doi=10.1159%2F000452138&volume=6&issue=2&pages=101-112&publication_year=2017&author=Kudo%2CM make?
- What's the monthly money flow for https://doi.org/10.1016%2FS0140-6736%2818%2930207-1?
- How much does http://scholar.google.com/scholar_lookup?&title=Lenvatinib%20versus%20sorafenib%20in%20first-line%20treatment%20of%20patients%20with%20unresectable%20hepatocellular%20carcinoma%3A%20a%20randomised%20phase%203%20non-inferiority%20trial&journal=The%20Lancet&doi=10.1016%2FS0140-6736%2818%2930207-1&volume=391&issue=10126&pages=1163-1173&publication_year=2018&author=Kudo%2CM&author=Finn%2CRS&author=Qin%2CS&author=Han%2CK-H&author=Ikeda%2CK&author=Piscaglia%2CF earn?
- How much does https://doi.org/10.7573%2Fdic.212533 make?
- http://scholar.google.com/scholar_lookup?&title=Regorafenib%20in%20hepatocellular%20carcinoma%3A%20latest%20evidence%20and%20clinical%20implications&journal=Drugs%20Context&doi=10.7573%2Fdic.212533&volume=7&publication_year=2018&author=Personeni%2CN&author=Pressiani%2CT&author=Santoro%2CA&author=Rimassa%2CL's financial summary
- How much revenue does https://doi.org/10.1016%2FS1470-2045%2818%2930937-9 produce monthly?
- http://scholar.google.com/scholar_lookup?&title=Ramucirumab%20after%20sorafenib%20in%20patients%20with%20advanced%20hepatocellular%20carcinoma%20and%20increased%20%CE%B1-fetoprotein%20concentrations%20%28REACH-2%29%3A%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930937-9&volume=20&issue=2&pages=282-296&publication_year=2019&author=Zhu%2CAX&author=Kang%2CY-K&author=Yen%2CC-J&author=Finn%2CRS&author=Galle%2CPR&author=Llovet%2CJM's total income per month
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Emerging%20therapies%20in%20advanced%20hepatocellular%20carcinoma&journal=Exp%20Hematol%20Oncol&doi=10.1186%2Fs40164-018-0109-6&volume=7&issue=1&publication_year=2018&author=Medavaram%2CS&author=Zhang%2CY?
- How much money does https://citation-needed.springer.com/v2/references/10.1007/s11010-022-04483-4?format=refman&flavour=references make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mahsa%20Pourhamzeh net monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mahsa%20Pourhamzeh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Samieh%20Asadian?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Samieh%20Asadian%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hamed%20Mirzaei?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hamed%20Mirzaei%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Azita%20Minaei?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Azita%20Minaei%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elahe%20Shahriari pull in monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elahe%20Shahriari%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anastasia%20Shpichka pull in monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anastasia%20Shpichka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hamidreza%20Aboulkheyr%20Es make?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hamidreza%20Aboulkheyr%20Es%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Timashev generate?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Timashev%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Moustapha%20Hassan have?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Moustapha%20Hassan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Massoud%20Vosough makes per month
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Massoud%20Vosough%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Novel%20antigens%20for%20targeted%20radioimmunotherapy%20in%20hepatocellular%20carcinoma&author=Mahsa%20Pourhamzeh%20et%20al&contentID=10.1007%2Fs11010-022-04483-4©right=The%20Author%28s%29%2C%20under%20exclusive%20licence%20to%20Springer%20Science%2BBusiness%20Media%2C%20LLC%2C%20part%20of%20Springer%20Nature&publication=0300-8177&publicationDate=2022-06-16&publisherName=SpringerNature&orderBeanReset=true produce monthly?
- What's the financial outcome of https://crossmark.crossref.org/dialog/?doi=10.1007/s11010-022-04483-4?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s11010-022-04483-4?format=refman&flavour=citation pull in monthly?
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's total income per month
- How much cash flow does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research have monthly?
- How much does https://www.springernature.com/gp/products earn?
- Explore the financials of https://www.springernature.com/gp/librarians
- Learn about the earnings of https://www.springernature.com/gp/societies
- How much does https://www.springernature.com/gp/partners gross monthly?
- What is the monthly revenue of https://www.springer.com/?
- How much does https://www.nature.com/ make?
- Find out how much https://www.biomedcentral.com/ earns monthly
- Explore the financials of https://www.palgrave.com/
- How much profit is https://www.apress.com/ making per month?
- What are the earnings of https://www.springernature.com/gp/legal/ccpa?
- What's the monthly income of https://www.springernature.com/gp/info/accessibility?
- Profit of https://support.springernature.com/en/support/home
- What are the total earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- https://www.springernature.com/'s total income per month
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref